首页|干扰circABCC4靶向微小RNA-185-5p抑制胰腺癌细胞发生发展

干扰circABCC4靶向微小RNA-185-5p抑制胰腺癌细胞发生发展

扫码查看
目的 探讨circABCC4对胰腺癌细胞发生发展的影响及分子机制.方法 收集2020年10月至2023年10月郑州大学第一附属医院收治的39例胰腺癌患者的癌组织及癌旁组织,用实时荧光定量聚合酶链反应(RT-qPCR)检测circABCC4和微小RNA(miR)-185-5p的表达水平;双荧光素酶报告实验检测circABCC4和miR-185-5p的靶向关系.将胰腺癌细胞SW1990分为si-circABCC4组、si-NC 组、miR-185-5p mimic 组、miR-NC 组、si-circABCC4+miR-185-5p inhibitor 组、si-circABCC4+抗miR-NC组;四甲基偶氮唑盐比色法(MTT)检测细胞增殖抑制率;克隆形成实验检测细胞克隆形成数;流式细胞术检测细胞凋亡率;蛋白质印迹法检测蛋白表达;Transwell检测细胞迁移和侵袭数.两组比较行t检验,多组间比较采用单因素方差分析,组间两两比较采用LSD-t检验.结果 胰腺癌组织中 circABCC4 表达水平高于癌旁组织(3.13±0.29 比 1.03±0.11,t=42.283,P<0.05),miR-185-5p 表达水平低于癌旁组织(0.45±0.08 比 1.09±0.17,t=21.273,P<0.05).circABCC4靶向结合并负调控miR-185-5p表达(P<0.05).si-circABCC4组SW1990细胞抑制率[(47.13±2.23)%比 0,F=2 376.899,P<0.05]、凋亡率[(18.94±1.08)%比(7.33±0.72)%,F=409.972,P<0.05)和B细胞淋巴瘤/白血病-2相关的x蛋白(bax)表达水平(0.55±0.04比0.21±0.03,F=310.551,P<0.05)高于 si-NC 组,克隆形成数[(67.44±3.44)个比(112.00±5.94)个,F=296.029,P<0.05]、B 细胞淋巴瘤/白血病-2(bcl-2)表达水平(0.27±0.03 比 0.67±0.05,F=236.571,P<0.05)低于 si-NC 组.miR-185-5p mimic 组 SW1990 细胞抑制率[(55.52±2.30)%比(0.02±0.01)%,F=2376.899,P<0.05]、凋亡率[(22.59±1.45)%比(7.11±0.55)%,F=409.972,P<0.05]和 bax 表达水平(0.65±0.04 比 0.20±0.02,F=310.551,P<0.05)高于 miR-NC组,克隆形成数[(54.11±2.23)个比(112.11±6.15)个,F=296.029,P<0.05]、bcl-2 表达水平(0.17±0.02 比 0.67±0.07,F=236.571,P<0.05)低于 miR-NC 组;si-circABCC4+miR-185-5p inhibitor 组 SW1990 细胞抑制率[(19.13±0.99)%比(47.09±1.73)%,F=2 376.899,P<0.05]、凋亡率[(10.25±0.57)%比(18.78±1.25)%,F=409.972,P<0.05]和 bax 表达水平(0.29±0.03 比 0.57±0.04,F=310.551,P<0.05)低于 si-circABCC4+抗 miR-NC 组,克隆形成数[(96.67±4.45)个比(65.78±2.86)个,F=296.029,P<0.05]、bcl-2 表达水平(0.52±0.04 比 0.26±0.03,F=236.571,P<0.05)高于 si-circABCC4+抗 miR-NC 组.si-circABCC4 组 SW1990 细胞迁移[(97.44±3.65)个 比(182.56±10.12)个,F=576.998,P<0.05]和侵袭数[(85.56±3.56)个 比(150.56±6.50)个,F=480.065,P<0.05]低于 si-NC 组;miR-185-5p mimic 组 SW1990 细胞迁移[(74.78±3.22)个 比(185.56±7.21)个,F=576.998,P<0.05]和侵袭数[(71.89±4.18)个 比(149.67±6.02)个,F=480.065,P<0.05]低于 miR-NC 组;si-circABCC4+miR-185-5p inhibitor 组 SW1990 细胞迁移[(158.67±6.15)个比(98.11±2.00)个,F=576.998,P<0.05]和侵袭数[(137.89±5.32)个比(85.00±3.40)个,F=480.065,P<0.05]高于 si-circABCC4+抗 miR-NC 组.结论 干扰circABCC4通过上调miR-185-5p抑制胰腺癌细胞的发生发展.
Interfering with circABCC4 targeting microRNA-185-5p to inhibit the development of pancreatic cancer cells
Objective To explore the influence of circABCC4 on the occurrence and development of pancreatic cancer cells and its molecular mechanism.Methods Cancer tissues and adjacent tissues were collected from 39 patients with pancreatic cancer admitted to our hospital from October 2020 to Octo-ber 2023.Real-time fluorescent quantitative polymerase chain reaction(RT-qPCR)was used to detect the expression levels of circABCC4 and miR-185-5p.The dual luciferase reporter experiment was used to de-tect the targeting relationship between circABCC4 and miR-185-5p.Pancreatic cancer cells SW1990 were divided into si-circABCC4 group,si-NC group,miR-185-5p mimic group,miR-NC group,si-circABCC4+miR-185-5p inhibitor group,si-circABCC4+anti-miR-NC group.The tetramethylazolium salt colorimetric method(MTT)was used to detect cell proliferation inhibition rate.The clone formation test was used to de-tect cell clone formation number.The flow cytometry was used to detect cell apoptosis rate.Western blot-ting was used to detect protein expression.Transwell assay was used to test number of migrating and inva-sive cells.This study represented the relevant data using mean±standard deviation((x)±s).The t-test was used for comparing two groups,one-way analysis of variance was used for comparing multiple groups,and LSD-t test was used for pairwise comparisons between groups.P<0.05 was considered to indicate a signifi-cant difference.Results Compared to adjacent tissues,the expression of circABCC4 was upregulated(3.13±0.29 vs.1.03±0.11,t=42.283,P<0.05)andtheexpressionofmiR-185-5pwasdownregu-lated(0.45±0.08 vs.1.09±0.17,t=21.273,P<0.05)in pancreatic cancer tissues.CircABCC4 tar-geted and negatively regulated miR-185-5p expression(P<0.05).Compared to the si-NC group,SW1990 cells'inhibition rate[(47.13±2.23)%vs.0,F=2 376.899,P<0.05],apoptosis rate[(18.94±1.08)%vs.(7.33±0.72)%,F=409.972,P<0.05],andB cell lymphoma/leukemia-2-associated x protein(bax)expression level(0.55±0.04 vs.0.21±0.03,F=310.551,P<0.05)were elevated in the si-circABCC4 group,while clone formation(67.44±3.44 vs.112.00±5.94,F=296.029,P<0.05)and B cell lymphoma/leukemia-2(bcl-2)expression level(0.27±0.03 vs.0.67±0.05,F=236.571,P<0.05)were decreased.Compared to the miR-NC group,SW1990 cells'inhibition rate[(55.52±2.30)%vs.(0.02±0.01)%,F=2 376.899,P<0.05],apoptosis rate[(22.59±1.45)%vs.(7.11±0.55)%,F=409.972,P<0.05],and bax expression level(0.65±0.04 vs.0.20±0.02,F=310.551,P<0.05)were elevated in the miR-185-5p mimic group,while clone formation(54.11±2.23 vs.112.11±6.15,F=296.029,P<0.05)and bcl-2 expression level(0.17±0.02 vs.0.67±0.07,F=236.571,P<0.05)were decreased.In comparison with the si-circABCC4+anti-miR-NC group,the si-circABCC4+miR-185-5p inhibitor group showed decreased SW1990 cell inhibition rate[(19.13±0.99)%vs.(47.09±1.73)%,F=2 376.899,P<0.05],apoptosis rate[(10.25±0.57)%vs.(18.78±1.25)%,F=409.972,P<0.05],and bax expression level(0.29±0.03 vs.0.57±0.04,F=310.551,P<0.05),as well as increased clone formation(96.67±4.45 vs.65.78±2.86,F=296.029,P<0.05),and bcl-2 expression level(0.52±0.04 vs.0.26±0.03,F=236.571,P<0.05).In comparison to the si-NC group,the si-circABCC4 group showed reduced SW1990 cell mi-gration(97.44±3.65 vs.182.56±10.12,F=576.998,P<0.05)and invasion(85.56±3.56 vs.150.56±6.50,F=480.065,P<0.05).Furthermore,compared to the miR-NC group,the miR-185-5p mimic group showed decreased SW1990 cell migration(74.78±3.22 vs.185.56±7.21,F=576.998,P<0.05)and invasion(71.89±4.18 vs.149.67±6.02,F=480.065,P<0.05).Lastly,in comparison to the si-circABCC4+anti-miR-NC group,the si-circABCC4+miR-185-5p inhibitor group exhibited increased SW1990 cell migration(158.67±6.15 vs.98.11±2.00,F=576.998,P<0.05)and invasion(137.89±5.32 vs.85.00±3.40,F=480.065,P<0.05).Conclusion Interference with circABCC4 inhibits the occurrence and development of pancreatic cancer cells by up-regulating miR-185-5p.

Pancreatic cancerMicroRNAProliferationApoptosisMigrationInvasion

于龙、张少康、李超博、高志强

展开 >

郑州大学第一附属医院肝胆胰外科河南省消化器官移植重点实验室,郑州 450052

胰腺癌 微小RNA 增殖 凋亡 迁移 侵袭

河南省医学科技攻关计划

LHGJ20220706

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(6)
  • 2